A carregar...

Effects of low-dose paroxetine 7.5 mg on weight and sexual function during treatment of vasomotor symptoms associated with menopause

OBJECTIVE: Two phase 3, randomized, placebo-controlled trials demonstrated that low-dose paroxetine 7.5 mg reduced the frequency and severity of vasomotor symptoms (VMS) associated with menopause and had a favorable tolerability profile. The impact of paroxetine 7.5 mg on body weight and sexual func...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Portman, David J., Kaunitz, Andrew M., Kazempour, Kazem, Mekonnen, Hana, Bhaskar, Sailaja, Lippman, Joel
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott-Raven Publishers 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4175016/
https://ncbi.nlm.nih.gov/pubmed/24552977
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/GME.0000000000000210
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!